On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Institut de Recherche sur le Cancer et le Vieillissement de Nice

InstitutionResearch output, impact & collaborations

Institut de Recherche sur le Cancer et le Vieillissement de Nice is a institution indexed in ScholarIQ from OpenAlex.

What is known about Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQrecord summary

Institut de Recherche sur le Cancer et le Vieillissement de Nice is a research organisation in Nice, FR. OpenAlex records 2,006 works and 260,495 citations for it. 412 researchers list it as their most recent affiliation.

How many works does Institut de Recherche sur le Cancer et le Vieillissement de Nice have?

ScholarIQindexed works

Institut de Recherche sur le Cancer et le Vieillissement de Nice has 2,006 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Institut de Recherche sur le Cancer et le Vieillissement de Nice →

How many citations does Institut de Recherche sur le Cancer et le Vieillissement de Nice have?

ScholarIQcitation count

Institut de Recherche sur le Cancer et le Vieillissement de Nice has 260,495 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Institut de Recherche sur le Cancer et le Vieillissement de Nice →

How many researchers are at Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQresearcher count

Institut de Recherche sur le Cancer et le Vieillissement de Nice has 412 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQavg h-index

Institut de Recherche sur le Cancer et le Vieillissement de Nice has an average h-index of 29 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQror

The ROR for Institut de Recherche sur le Cancer et le Vieillissement de Nice is on the source record.

Open the ROR →

What is the OpenAlex record for Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQopenalex

The OpenAlex for Institut de Recherche sur le Cancer et le Vieillissement de Nice is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQtop researchers by citations

J. Doyen · Colorectal Cancer Surgical Treatments

255 works3,014 citations

What are the most-cited papers on Institut de Recherche sur le Cancer et le Vieillissement de Nice?

ScholarIQmost cited works

Prognostic factors in 1038 women with metastatic breast cancer

R. Largillier, Jean-Marc Ferrero, J. Doyen, Jérôme Barrière, M. Namer, Véronique Mari, A. Courdi, Jean‐Michel Hannoun‐Lévi, F. Ettore, Isabelle Birtwisle‐Peyrottes, C. Balu–Maestro, Pierre Yves Marcy, I. Raoust, M. Lallement, Emmanuel Chamorey

Annals of Oncology. 2008380 CitationsOPEN ACCESS

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

Sébastien Grosso, J. Doyen, Scott K. Parks, Thomas Bertero, Alexandra Paye, Bruno Cardinaud, Pierre Gounon, Sandra Lacas‐Gervais, Agnès Noël, Jacques Pouysségur, Pascal Barbry, Nathalie M. Mazure, Bernard Mari

Cell Death and Disease. 2013214 CitationsOPEN ACCESS

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

J. Doyen, C. Trastour, F. Ettore, Isabelle Peyrottes, N. Toussant, Jocelyn Gal, Karine Ilc, Damien Roux, Scott K. Parks, Jean-Marc Ferrero, Jacques Pouysségur

Biochemical and Biophysical Research Communications. 2014114 CitationsOPEN ACCESS

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, Ana-Maria Mușină, Maria-Gabriela Aniței, Alfredo Romero, Florence Marliot, Audelaure Junca, J. Doyen, Bernhard Mlecnik, Nacilla Haicheur, Tessa Fredriksen, Christine Lagorce, Anne Jouret‐Mourin, Daniel Léonard, Frédéric Bibeau, Soledad Iseas, Enrique Roca, Ana Cabanne, Carlos Vaccaro, Juan Pablo Santino, Eduardo Huertas, David Tougeron, Carlos Carvalho, Nuno Figueiredo, Rodrigo Oliva Perez, Angelita Habr‐Gama, Viorel Scripcariu, Jean‐Pierre Gérard, Jérôme Galon, Guy Zeitoun, Franck Pagès

Clinical Cancer Research. 2020110 CitationsOPEN ACCESS

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria, J. Doyen, Marta Jarlier, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, G. Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, S. Gourgou-Bourgade, Béata Juzyna, Thierry Conroy, J.P. Gérard

Annals of Oncology. 2017106 CitationsOPEN ACCESS

How much of the research on Institut de Recherche sur le Cancer et le Vieillissement de Nice is open access?

ScholarIQopen access share

64%OPEN ACCESS

Gold

18%

Green

Hybrid

Bronze

36%

Closed

36%